China’s drug regulator clears mpox vaccine; to undergo clinical trial
Beijing, Sep 10: China’s top drug regulator has cleared a mpox vaccine developed by local drug firm Sinopharm for clinical trials which could be the country’s first experimental dose to battle the deadly disease.
The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.
There is currently no approved mpox vaccine in China. Globally, a few vaccines have been approved in the United States, Canada, the European Union, Japan and Russia.
In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval.
The process can take years, even decades. However, the National Medical Products Administration, China's top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need, state-run China Daily reported on Tuesday.
According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA.
The description is the same as Jynneos, the world's first mpox vaccine approved by the Food and Drug Administration in the United States in 2019.
The World Health Organisation said on August 14 that the mpox outbreak in Africa constitutes a public health emergency of international concern — its highest form of alert.
Previously, in July 2022, the WHO declared a global emergency but then lifted it in May last year because of a sustained decline in international cases.
So far, more than 120 countries and regions across the world have reported more than 100,000 confirmed infections and 226 related deaths.
China reported its first imported case in September 2022 and the first domestic case in June last year.
By the end of July, the nation had reported 2,567 confirmed cases, according to the China Daily report.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Karnataka govt to discuss Bill on levying cess to gig workers during winter session
Bengaluru: The state government is likely to introduce in the winter session of the Karnataka Assembly this year a Bill to levy a cess that will fund the welfare of gig workers, an issue that is being discussed for several months.
The quantum to be levied as cess for the welfare of the workers is yet to be confirmed and there is also ambiguity in the draft Karnataka Platform-based Gig Workers (Social Security and Welfare) Bill regarding the calculation of the cess to be levied. The authorities concerned are yet to decide if the cess should be levied as per transaction or based on the state-specific turnover of an aggregator, Deccan Herald reports.
Mohammed Mohsin, Principal Secretary of the Labour Department has said that the Department had already held 20 to 25 rounds of discussions on the matters with the stakeholders. A levy of cess as per transaction was preferred by both parties since the aggregators do not usually disclose their total turnover.
ALSO READ: Tumakuru: Senior BJP leader Sogadu Shivanna assaulted by party activist
The Bill drafted proposes to set up a Karnataka Gig Worker’s Social Security and Welfare Fund, inclusive of money from the cess, government grant as well as contributions by individual platform-based gig workers.
During the Karnataka Assembly elections of 2023 too, the Congress had promised in its manifesto efforts for the welfare of gig workers. The party had also assured the workers that a Karnataka Platform-based Gig Workers’ Welfare Board would be set up with Rs 3,000-crore seed money as a revolving fund.
The Niti Aayog report of 2022 has stated that the gig workforce is expected to expand to 2.35 crore by 2029-30, which makes the Bill crucial.
Citing the provisions of the Centre’s Social Security Code, 2020, Babu Mathew from the Centre for Labour Studies at the National Law School of India University (NLSIU) also opined that contribution by an aggregator shall not cross 5 per cent of the amount that is paid or payable to either gig or platform workers.
